NCT02113787View on ClinicalTrials.gov

Switchability Study Between Brand and Generic Topiramate

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

May 31, 2017

Conditions
Epilepsy
Interventions
PROCEDURE

Pharmacokinetic study

Patients who are examen pharmacokinetic study after taking Topamax or Topiramate during 7 days

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02113787 - Switchability Study Between Brand and Generic Topiramate | Biotech Hunter | Biotech Hunter